{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:02Z","timestamp":1790803682458,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ctrv.2020.102087","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T20:56:03Z","timestamp":1596833763000},"page":"102087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Current management and future perspectives of penile cancer: An updated review"],"prefix":"10.1016","volume":"90","author":[{"given":"Florent","family":"Peyraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-8019","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Allenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Gross-Goupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Domblides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Daste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokrane","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Haaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2020.102087_b0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2020.102087_b0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.urology.2010.03.003","article-title":"Epidemiology and natural history of penile cancer","volume":"76","author":"Pow-Sang","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ctrv.2020.102087_b0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","article-title":"Penile cancer: epidemiology, pathogenesis and prevention","volume":"27","author":"Bleeker","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.currproblcancer.2015.03.010","article-title":"Epidemiology of penile cancer","volume":"39","author":"Christodoulidou","year":"2015","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5409\/wjcp.v6.i1.89","article-title":"Early infant male circumcision: systematic review, risk-benefit analysis, and progress in policy","volume":"6","author":"Morris","year":"2017","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.ctrv.2020.102087_b0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bju.13534","article-title":"Socioeconomic factors and penile cancer risk and mortality; a population-based study","volume":"119","author":"Torbrand","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0035","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/s41598-020-59831-5","article-title":"Profile of patients with penile cancer in the region with the highest worldwide incidence","volume":"10","author":"Vieira","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctrv.2020.102087_b0040","first-page":"449","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.ctrv.2020.102087_b0045","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ctrv.2020.102087_b0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.21037\/tau.2017.06.27","article-title":"Relationship between human papillomavirus and penile cancer-implications for prevention and treatment","volume":"6","author":"Kidd","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0060","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2007.12.3182","article-title":"Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma","volume":"25","author":"Heideman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jclinpath-2015-202911","article-title":"Review of in situ and invasive penile squamous cell carcinoma and associated non-neoplastic dermatological conditions","volume":"68","author":"Downes","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ctrv.2020.102087_b0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part A: Renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/LGT.0000000000000159","article-title":"Lesions and neoplasms of the penis: a review","volume":"20","author":"Heller","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ctrv.2020.102087_b0080","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ctrv.2020.102087_b0085","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2010.08.015","article-title":"Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients","volume":"58","author":"Graafland","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0090","unstructured":"NCCN clinical practice guidelines in oncology: penile cancer v1.2019; 2019. www.nccn.org\/professionals\/physiciangls\/pdf\/penile.pdf."},{"key":"10.1016\/j.ctrv.2020.102087_b0095","unstructured":"Hakenberg OW, Comp\u00e9rat E, Minhas S, Necchi A, Protzel C, Watkin N. EAU Guidelines on Penile Cancer; 2019. https:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/."},{"key":"10.1016\/j.ctrv.2020.102087_b0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jso.20980","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian national cancer institute long-term experience","volume":"97","author":"Ornellas","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0105","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","article-title":"Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control","volume":"188","author":"Philippou","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0110","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1464-410X.2005.05769.x","article-title":"What surgical resection margins are required to achieve oncological control in men with primary penile cancer?","volume":"96","author":"Minhas","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","article-title":"Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients","volume":"54","author":"Leijte","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-9-8","article-title":"Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer","volume":"9","author":"Maddineni","year":"2009","journal-title":"BMC Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eururo.2012.02.052","article-title":"Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents","volume":"62","author":"Alnajjar","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.21037\/tau.2017.06.24","article-title":"Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity","volume":"6","author":"Manjunath","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2017.01.024","article-title":"Need for evidence and consensus on laser treatment for management of select primary penile tumors","volume":"72","author":"Leone","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clon.2006.01.004","article-title":"External-beam radiotherapy in T1\u20132 N0 penile carcinoma","volume":"18","author":"Azrif","year":"2006","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.ctrv.2020.102087_b0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2017.02.090","article-title":"Brachytherapy for conservative treatment of invasive penile carcinoma: prognostic factors and long-term analysis of outcome","volume":"99","author":"Escande","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2020.102087_b0150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2006.06368.x","article-title":"Total glans resurfacing for premalignant lesions of the penis: initial outcome data","volume":"98","author":"Hadway","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0155","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.juro.2007.07.039","article-title":"Mohs micrographic surgery for penile cancer: management and long-term followup","volume":"178","author":"Shindel","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","article-title":"Penile sparing surgery for penile cancer-does it affect survival?","volume":"192","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bju.14037","article-title":"Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature","volume":"121","author":"Chipollini","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0170","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1111\/j.1464-410X.2012.11437.x","article-title":"Dynamic sentinel node biopsy in penile cancer: initial experiences at a Swedish referral centre","volume":"111","author":"Kirrander","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eururo.2016.09.048","article-title":"Glansectomy and split-thickness skin graft for penile cancer","volume":"73","author":"Parnham","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0180","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.eururo.2007.02.038","article-title":"Reconstructive surgery for invasive squamous carcinoma of the glans penis","volume":"52","author":"Smith","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1464-410X.2004.05153.x","article-title":"Organ-sparing surgery for invasive penile cancer: early follow-up data","volume":"94","author":"Pietrzak","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000020298","article-title":"Is conservative organ-sparing treatment of penile carcinoma justified?","volume":"38","author":"Gotsadze","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0195","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.urology.2010.04.009","article-title":"New developments in the treatment of localized penile cancer","volume":"76","author":"Solsona","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ctrv.2020.102087_b0200","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.eururo.2009.02.021","article-title":"Lymphadenectomy in the surgical management of penile cancer","volume":"55","author":"Protzel","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.20414","article-title":"Prognostic factors in node-positive carcinoma of the penis","volume":"93","author":"Pandey","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0210","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0215","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bju.12677","article-title":"Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis","volume":"116","author":"Sun","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0220","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/bjc.2015.141","article-title":"Modification of N staging systems for penile cancer: a more precise prediction of prognosis","volume":"112","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0225","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s11255-016-1405-x","article-title":"Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis","volume":"48","author":"Zou","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ctrv.2020.102087_b0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00345-008-0324-6","article-title":"Contemporary inguinal lymph node dissection: minimizing complications","volume":"27","author":"Spiess","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0235","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.eururo.2012.10.035","article-title":"Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution","volume":"63","author":"Lam","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0240","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2008.20.6870","article-title":"Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis","volume":"27","author":"Leijte","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0245","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1245\/s10434-010-1546-6","article-title":"Dynamic sentinel node biopsy for inguinal lymph node staging in patients with penile cancer: a systematic review and cumulative analysis of the literature","volume":"18","author":"Neto","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0250","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1016\/S1569-9056(13)60879-9","article-title":"394 Value of dynamic sentinel node biopsy, ultrasound and fine needle aspiration in the detection of metastatic lymph nodes in penile cancer","volume":"12","author":"Djajadiningrat","year":"2013","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.ctrv.2020.102087_b0255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11255-015-1182-y","article-title":"Saphenous vein sparing during laparoscopic bilateral inguinal lymphadenectomy for penile carcinoma patients","volume":"48","author":"Cui","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ctrv.2020.102087_b0260","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.juro.2013.06.016","article-title":"Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes","volume":"190","author":"Koifman","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0265","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bju.13660","article-title":"Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period","volume":"119","author":"Kumar","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bjps.2012.09.030","article-title":"Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications","volume":"66","author":"Tauber","year":"2013","journal-title":"J Plast Reconstr Aesthetic Surg JPRAS"},{"key":"10.1016\/j.ctrv.2020.102087_b0275","first-page":"1391","article-title":"A comparison of fibrin sealant versus standard closure in the reduction of postoperative morbidity after groin dissection: a systematic review and meta-analysis","volume":"40","author":"Weldrick","year":"2014","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0280","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2011.10.033","article-title":"Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis","volume":"187","author":"Souillac","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0290","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ucl.2010.04.005","article-title":"Controversies in ilioinguinal lymphadenectomy","volume":"37","author":"Hegarty","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ctrv.2020.102087_b0295","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2013.02.037","article-title":"Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis","volume":"64","author":"Stuiver","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0300","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.juro.2010.03.140","article-title":"Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome","volume":"184","author":"Yao","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0305","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.juro.2014.12.019","article-title":"Prophylactic pelvic lymph node dissection in patients with penile cancer","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0310","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.juro.2017.01.059","article-title":"Penile cancer: contemporary lymph node management","volume":"197","author":"O\u2019Brien","year":"2017","journal-title":"J Urol"},{"issue":"548\u2013555","key":"10.1016\/j.ctrv.2020.102087_b0315","article-title":"Clinical outcomes of perioperative chemotherapy in patients with locally advanced penile squamous-cell carcinoma: results of a multicenter analysis","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0320","doi-asserted-by":"crossref","first-page":"531.e7","DOI":"10.1016\/j.urolonc.2019.04.003","article-title":"Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: a retrospective multicenter study","volume":"37","author":"Necchi","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0325","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bju.12946","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","volume":"117","author":"Dickstein","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0330","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0340","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/jco.2014.32.4_suppl.377","article-title":"Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): Results of a single high-volume center","volume":"32","author":"Giannatempo","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0345","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0350","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0355","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0360","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1200\/JCO.2018.36.15_suppl.4514","article-title":"VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis (CRUK\/12\/021)","volume":"36","author":"Pickering","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0365","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12885-019-5847-2","article-title":"Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0370","doi-asserted-by":"crossref","DOI":"10.1111\/bju.15177","article-title":"A risk calculator predicting recurrence in lymph node metastatic penile cancer","author":"Bandini","year":"2020","journal-title":"BJU Int"},{"issue":"496","key":"10.1016\/j.ctrv.2020.102087_b0375","first-page":"e17","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0380","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol Ann"},{"key":"10.1016\/j.ctrv.2020.102087_b0385","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","article-title":"A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings","volume":"14","author":"Nicolai","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0390","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","article-title":"Prognostic factors of adjuvant taxane, cisplatin, and 5-fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0395","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node-positive penile cancer: a systematic review by the european association of urology penile cancer guidelines panel","volume":"74","author":"Robinson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0400","doi-asserted-by":"crossref","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","article-title":"Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"35","author":"Tang","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0405","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.euf.2018.10.007","article-title":"Primary penile cancer: the role of adjuvant radiation therapy in the management of extranodal extension in lymph nodes","volume":"5","author":"Johnstone","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ctrv.2020.102087_b0410","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eursup.2017.07.003","article-title":"Systemic therapy for penile cancer","volume":"17","author":"Necchi","year":"2018","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.ctrv.2020.102087_b0415","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0420","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0425","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0430","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.urology.2010.03.082","article-title":"Treatment of visceral, unresectable, or bulky\/unresectable regional metastases of penile cancer","volume":"76","author":"Pettaway","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ctrv.2020.102087_b0435","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","article-title":"Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes","volume":"85","author":"Wang","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.ctrv.2020.102087_b0440","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.urolonc.2007.10.015","article-title":"Cisplatin and gemcitabine in the management of metastatic penile cancer","volume":"27","author":"Power","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0445","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0450","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis","volume":"29","author":"Necchi","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0455","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bju.14013","article-title":"First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0460","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-14-0284","article-title":"Genomic profiling of human penile carcinoma predicts worse prognosis and survival","volume":"8","author":"Busso-Lopes","year":"2015","journal-title":"Cancer Prev Res Phila Pa"},{"key":"10.1016\/j.ctrv.2020.102087_b0465","doi-asserted-by":"crossref","unstructured":"La-Touche S, Lemetre C, Lambros M, Stankiewicz E, Ng CKY, Weigelt B, et al. DNA copy number aberrations, and human papillomavirus status in penile carcinoma. clinico-pathological correlations and potential driver genes. PloS One 2016; 11:e0146740. https:\/\/doi.org\/10.1371\/journal.pone.0146740.","DOI":"10.1371\/journal.pone.0146740"},{"key":"10.1016\/j.ctrv.2020.102087_b0470","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","article-title":"Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy","volume":"75","author":"McDaniel","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2020.102087_b0475","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","article-title":"Comprehensive genomic profiling of advanced penile carcinoma suggests a high frequency of clinically relevant genomic alterations","volume":"21","author":"Ali","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2020.102087_b0480","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.juro.2018.09.056","article-title":"Comparative genomic profiling of refractory and metastatic penile and nonpenile cutaneous squamous cell carcinoma: implications for selection of systemic therapy","volume":"201","author":"Jacob","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0485","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ijc.32373","article-title":"Mutational landscape of penile squamous cell carcinoma in a Chinese population","volume":"145","author":"Wang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0490","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1827.2008.02259.x","article-title":"Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men","volume":"58","author":"Yanagawa","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.ctrv.2020.102087_b0495","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","article-title":"Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis","volume":"65","author":"Gunia","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ctrv.2020.102087_b0500","first-page":"433.e19","article-title":"Epithelial-mesenchymal transition (EMT) phenotype at invasion front of squamous cell carcinoma of the penis influences oncological outcomes","volume":"34","author":"da Cunha","year":"2016","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.ctrv.2020.102087_b0505","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13402-012-0098-0","article-title":"Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study","volume":"35","author":"Minardi","year":"2012","journal-title":"Cell Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0510","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00428-008-0590-0","article-title":"Down-regulation of the metastasis suppressor protein KAI1\/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma","volume":"452","author":"Protzel","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ctrv.2020.102087_b0515","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.juro.2013.06.015","article-title":"mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior","volume":"190","author":"Ferrandiz-Pulido","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198905","article-title":"PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer","volume":"13","author":"Adimonye","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctrv.2020.102087_b0525","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.18632\/oncotarget.24688","article-title":"Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway","volume":"9","author":"Adimonye","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2020.102087_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2018.03.056","article-title":"The prognostic value of PIK3CA copy number gain in penile cancer","author":"Adimonye","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.ctrv.2020.102087_b0535","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.euf.2016.08.001","article-title":"Gene expression profiling of advanced penile squamous cell carcinoma receiving cisplatin-based chemotherapy improves prognostication and identifies potential therapeutic targets","volume":"4","author":"Necchi","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ctrv.2020.102087_b0540","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euf.2017.02.009","article-title":"E2F1 signalling is predictive of chemoresistance and lymphogenic metastasis in penile cancer: a pilot functional study reveals new prognostic biomarkers","volume":"4","author":"Fenner","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ctrv.2020.102087_b0545","doi-asserted-by":"crossref","unstructured":"Heller M, Prigge E-S, Kaczorowski A, Doeberitz M von K, Hohenfellner M, Duensing S. APOBEC3A expression in penile squamous cell carcinoma. Pathobiology 2018; 85: 169\u201378. https:\/\/doi.org\/10.1159\/000479007.","DOI":"10.1159\/000479007"},{"key":"10.1016\/j.ctrv.2020.102087_b0550","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00428-018-2404-3","article-title":"Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor","volume":"473","author":"Kuasne","year":"2018","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.ctrv.2020.102087_b0555","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2340\/00015555-3004","article-title":"Changes in androgen receptor expression as a molecular marker of progression from normal epithelium to invasive cancer in elderly patients with penile squamous cell carcinoma","volume":"98","author":"Gaetano Vellone","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ctrv.2020.102087_b0560","first-page":"1091","article-title":"Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma","volume":"41","author":"Hu","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ctrv.2020.102087_b0565","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.urolonc.2019.04.013","article-title":"Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma","volume":"37","author":"Hu","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0570","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-020-0297-9","article-title":"Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers","author":"Maia","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0575","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1200\/JCO.2020.38.6_suppl.6","article-title":"Genomic landscape of circulating tumor (ct)-DNA alterations in patients with penile cancer","volume":"38","author":"Nassar","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0580","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","article-title":"Molecular and genetic pathways in penile cancer","volume":"8","author":"Kayes","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0585","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/modpathol.2009.77","article-title":"HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis","volume":"22","author":"Stankiewicz","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2020.102087_b0590","first-page":"481","article-title":"Pathophysiological basis of human papillomavirus in penile cancer: key to prevention and delivery of more effective therapies","volume":"66","author":"Spiess","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2020.102087_b0595","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","article-title":"Alterations in the tumor suppressor gene p16 INK4A are associated with aggressive behavior of penile carcinomas","volume":"458","author":"Poetsch","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ctrv.2020.102087_b0600","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.juro.2011.10.149","article-title":"p16INK4a is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study","volume":"187","author":"Gunia","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0605","doi-asserted-by":"crossref","unstructured":"Martins V de A, Pinho JD, Teixeira J\u00fanior AAL, Nogueira LR, Silva FF, Maulen VE, et al. P16INK4a expression in patients with penile cancer. PLOS ONE 2018; 13: e0205350. https:\/\/doi.org\/10.1371\/journal.pone.0205350.","DOI":"10.1371\/journal.pone.0205350"},{"key":"10.1016\/j.ctrv.2020.102087_b0610","doi-asserted-by":"crossref","unstructured":"Chahoud J, Pham R, Guo M, Pickering CR, Qiao W, Khanna A, et al. p16INK4a expression and survival outcomes in patients with penile squamous cell carcinoma: The M.D. Anderson Cancer Center Experience. J Clin Oncol 2020; 38: 5\u20135. https:\/\/doi.org\/10.1200\/JCO.2020.38.6_suppl.5.","DOI":"10.1200\/JCO.2020.38.6_suppl.5"},{"key":"10.1016\/j.ctrv.2020.102087_b0615","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.juro.2014.08.087","article-title":"Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0620","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.clgc.2018.09.012","article-title":"Impact of PI3K-AKT-mTOR signaling pathway up-regulation on prognosis of penile squamous-cell carcinoma: results from a tissue microarray study and review of the literature","volume":"17","author":"Azizi","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctrv.2020.102087_b0625","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/sextrans-2012-050980","article-title":"HPV vaccine acceptability among men: a systematic review and meta-analysis","volume":"89","author":"Newman","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ctrv.2020.102087_b0630","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","article-title":"Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review","volume":"16","author":"Harder","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.ctrv.2020.102087_b0635","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0640","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1269047","article-title":"Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma","volume":"6","author":"Deng","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctrv.2020.102087_b0645","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","article-title":"Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status","volume":"197","author":"Ottenhof","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2020.102087_b0650","article-title":"PD-L1 expression in men with penile cancer and its association with clinical outcomes","author":"Davidsson","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0655","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","article-title":"The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma","volume":"9","author":"Ottenhof","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctrv.2020.102087_b0660","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.2020.38.6_suppl.4","article-title":"Tumor immune microenvironment alterations in penile squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches","volume":"38","author":"Chahoud","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102087_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2019.02.019","article-title":"Defining the tumor microenvironment of penile cancer by means of the cancer immunogram","author":"de Vries","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"41","key":"10.1016\/j.ctrv.2020.102087_b0670","first-page":"300","article-title":"Evidence for efficacy of treatment with the anti-PD-1 mab nivolumab in radiation and multichemorefractory advanced penile squamous cell carcinoma","volume":"2018","author":"Trafalis","year":"1997","journal-title":"J Immunother Hagerstown Md"},{"key":"10.1016\/j.ctrv.2020.102087_b0675","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000495251","article-title":"No evidence of microsatellite instability and loss of mismatch-repair-protein expression in squamous cell carcinoma of the penis","volume":"86","author":"Stoehr","year":"2019","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220301250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220301250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:22:24Z","timestamp":1759656144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737220301250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":135,"alternative-id":["S0305737220301250"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.102087","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current management and future perspectives of penile cancer: An updated review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.102087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102087"}}